Lexaria, a global innovator in drug delivery platforms, has, since 2016, proven its patented DehydraTECH(TM) technology, asserting its superiority in improving drug bioavailability
This has earned it 39 granted patents, with many pending globally
DehydraTECH has a number of potential pharmaceutical applications with successful early stage results in hypertension, diabetes and weight loss and many others With its focus on GLP-1 clinical studies for 2024, Lexaria looks to carve out greater market share to make 2024 its biggest year
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has been pushing the envelope and redefining drug delivery technology. Its patented DehydraTECH(TM) technology has proven itself in numerous studies since 2016, highlighting its ability to increase bio-absorption compared to standard industry formulations while also reducing time of onset, as well as delivering drugs more effectively across the blood brain barrier (https://cnw.fm/iZZZR).
The technology’s effectiveness and uniqueness have earned it 39 granted patents, with many patents pending globally. DehydraTECH has a number of potential pharmaceutical applications, a testament to its versatility and overall effectiveness. The key factor that has played a role in its adoption is its unique ability to improve drug bioavailability, a critical marker and determinant in overall drug effectiveness.
Bioavailability can be described as the extent to which a substance or drug becomes entirely available for its intended biological destination (https://cnw.fm/uH82n). It may also be referred to as a measure of the rate and fraction of the initial drug dose that ultimately gets to the targeted part of the body (https://cnw.fm/bsUUT). Usually, the higher the bioavailability, the more effective the drug, and since time immemorial, scientists have been exploring various ways to improve it.
Studies have highlighted several factors that have shown to affect drug bioavailability, particularly for orally administered drugs. These include decomposition of the medication in the lumen, hepatic fist-pass impact, surface and time accessible for retention, as well as pH and perfusion of the small digestive system.
Lexaria, through its DehydraTECH technology, enhances the performance of several categories of fat-soluble active molecules and drugs, ultimately improving their bioavailability and efficiency. This is achieved by mixing the active ingredients as a delivery “payload” with specific fatty acids, infusing the mixture into a substrate material, and then using controlled dehydration synthesis processing to associate the payload and fatty acids together at a molecular level. This is followed by integrating the newly combined molecules into end-product production across various dosage form factors (https://cnw.fm/iAUAI).
With this technology, Lexaria looks to tap into various growing markets, among them the cardiovascular drugs market and the diabetes markets, both projected to be valued at $115.8 billion and $134.1 billion by 2028 and 2030, respectively. It also hopes to make drugs more effective, possibly reducing the cost of treatment and the patients’ overall quality of life. The company is also aggressively pushing for its patent applications and approvals globally, a show of commitment to creating shareholder value. In addition to its focus on GLP-1 clinical studies for the 2024 calendar year, Lexaria is confident that it will carve out a decent market share for itself, ultimately making 2024 its biggest year yet.
NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
“Dictators are not in the business of allowing elections that could remove them from their thrones.”—Gene Sharp, political science professor
The U.S. Supreme Court was right to keep President Trump’s name on the ballot.
The high court’s decree that the power to remove a federal candidate from the ballot under the Constitution’s “insurrectionist ban” rests with Congress, not the states, underscores the fact that in a representative democracy, the citizenry—not the courts, not the corporations, and not the contrived electoral colleges—should be the ones to elect their representatives.
Unfortunately, what is being staged is not an election. It is a mockery of an election.
This year’s presidential election, much like every other election in recent years, is what historian Daniel Boorstin referred to as a “pseudo-event”: manufactured, contrived, confected and devoid of any intrinsic value save the value of being advertised.
For the next eight months, Americans will be dope-fed billions of dollars’ worth of political propaganda aimed at persuading them that 1) their votes count, 2) the future of this nation—nay, our very lives—depends on who we elect as president, and 3) electing the right candidate will fix everything that is wrong with this country.
Incredible, isn’t it, that in a country of more than 330 million people, we are given only two choices for president?
The system is rigged, of course.
Forcing the citizenry to choose between two candidates who are equally unfit for office does not in any way translate to having some say in how the government is run.
Indeed, no matter what names are on the presidential ballot, once you step away from the cult of personality politics, you’ll find that beneath the power suits, they’re all alike.
The candidate who wins the White House has already made a Faustian bargain to keep the police state in power.
We’ve been down this road before.
Barack Obama campaigned on a message of hope, change and transparency, and promised an end to war and surveillance. Yet under Obama, government whistleblowers were routinely prosecuted, U.S. arms sales skyrocketed, police militarization accelerated, and surveillance became widespread.
Donald Trump swore to drain the swamp in Washington DC. Instead of putting an end to the corruption, however, Trump paved the way for lobbyists, corporations, the military industrial complex, and the Deep State to feast on the carcass of the dying American republic.
We’ve been mired in this swamp for decades now.
Joe Biden has been no different. If his job was to keep the Deep State in power, he’s been a resounding success.
Follow the money. It always points the way.
With each new president, we’ve been subjected to more government surveillance, more police abuse, more SWAT team raids, more roadside strip searches, more censorship, more prison time, more egregious laws, more endless wars, more invasive technology, more militarization, more injustice, more corruption, more cronyism, more graft, more lies, and more of everything that has turned the American dream into the American nightmare.
What we’re not getting more of: elected officials who actually represent us.
No matter who wins the presidential election come November, it’s a sure bet that the losers will be the American people if all we’re prepared to do is vote.
After all, there is more to citizenship than the act of casting a ballot for someone who, once elected, will march in lockstep with the dictates of the powers-that-be.
Yet as long as Americans are content to let politicians, war hawks and Corporate America run the country, the police state will prevail.
“Total continuity” is how Chris Hedges refers to the manner in which the government’s agenda remains unchanged no matter who occupies the Executive Branch. “Continuity of government” (COG) is the phrase policy wonks use to refer to the unelected individuals who have been appointed to run the government in the event of a “catastrophe.”
You can also refer to it as a shadow government, or the Deep State, which is comprised of unelected government bureaucrats, corporations, contractors, paper-pushers, and button-pushers who actually call the shots behind the scenes.
Whatever term you use, the upshot remains the same: on the national level, we’re up against an immoveable, intractable, entrenched force that is greater than any one politician or party, whose tentacles reach deep into every sector imaginable, from Wall Street, the military and the courts to the technology giants, entertainment, healthcare and the media.
This is no Goliath to be felled by a simple stone.
This is a Leviathan disguised as a political savior.
So, what is the solution to this blatant display of imperial elitism disguising itself as a populist exercise in representative government?
Stop playing the game. Stop supporting the system. Stop defending the insanity. Just stop.
Washington thrives on money, so stop giving them your money. Stop throwing your hard-earned dollars away on politicians and Super PACs who view you as nothing more than a means to an end. There are countless worthy grassroots organizations and nonprofits—groups like The Rutherford Institute—working to address real needs like injustice, poverty, homelessness, etc. Support them and you’ll see change you really can believe in in your own backyard.
Politicians depend on votes, so stop giving them your vote unless they have a proven track record of listening to their constituents, abiding by their wishes and working hard to earn and keep their trust.
It’s comforting to believe that your vote matters, but presidents are selected, not elected. Despite what is taught in school and the propaganda that is peddled by the media, a presidential election is not a populist election for a representative. Rather, it’s a gathering of shareholders to select the next CEO, a fact reinforced by the nation’s archaic electoral college system. In other words, your vote doesn’t elect a president. Despite the fact that there are 218 million eligible voters in this country (only half of whom actually vote), it is the electoral college, made up of 538 individuals handpicked by the candidates’ respective parties, that actually selects the next president.
The only thing you’re accomplishing by taking part in the “reassurance ritual” of voting is sustaining the illusion that we have a democratic republic.
In actuality, we are suffering from what political scientists Martin Gilens and Benjamin Page more accurately term an “economic élite domination” in which the economic elite (lobbyists, corporations, monied special interest groups) dominate and dictate national policy.
No surprise there.
As an in-depth Princeton University study confirms, democracy has been replaced by oligarchy, a system of government in which elected officials represent the interests of the rich and powerful rather than the average citizen.
As such, presidential elections merely serve to maintain the status quo. Once elected president, that person becomes part of the dictatorial continuum that is the American imperial presidency today.
So how do we prevail against the tyrant who says all the right things and does none of them? How do we overcome the despot whose promises fade with the spotlights? How do we conquer the dictator whose benevolence is all for show?
We get organized. We get educated. We get active.
Whether you vote or don’t vote doesn’t really matter. What matters is what else you’re doing to push back against government incompetence, abuse, corruption, graft, fraud and cronyism.
Don’t be fooled into thinking that the only road to reform is through the ballot box.
If you feel led to vote, fine, but if all you do is vote, “we the people” are going to lose.
If you abstain from voting and still do nothing, “we the people” are going to lose.
If you give your proxy to some third-party individual or group to fix what’s wrong with the country and that’s all you do, then “we the people” are going to lose.
If, however, you’re prepared to turn off the television, tune out the talking heads, untether yourself from whatever piece of technology you’re affixed to, wean yourself off the teat of the nanny state, and start flexing those unused civic muscles, then there might be hope for us all.
For starters, know your rights and then put that knowledge into action. What we desperately need is a concerted, collective commitment to the Constitution’s principles of limited government, a system of checks and balances, and a recognition that they—the president, Congress, the courts, the military, the police, the technocrats and plutocrats and bureaucrats—answer to and are accountable to “we the people.”
Second, think nationally but act locally. Understand how your local government is structured. Who serves on your city council and school boards? What recourse does the community have to voice concerns about local problems or disagree with decisions by government officials? Are your locally elected officials accessible and open to what you have to say? Are your police chiefs being appointed from within your community? Who runs your local media? Does your newspaper report on local events? Who are your judges?
Third, don’t stop doing the hard work of holding your government accountable. Don’t let personal politics and party allegiances blind you to government misconduct and power grabs. This will mean holding all three branches of government accountable to the Constitution (i.e., vote them out of office if they abuse their powers). And it will mean making the president play by the rules of the Constitution.
Finally, don’t remain silent in the face of government injustice, corruption, or ineptitude. Speak truth to power.
A healthy, representative government is hard work. It takes a citizenry that is informed about the issues, educated about how the government operates, and willing to make the sacrifices necessary to stay involved. It also takes a citizenry willing to do more than grouse and complain.
We must act—and act responsibly.
As I make clear in my book Battlefield America: The War on the American People and in its fictional counterpart The Erik Blair Diaries, any hope of restoring our freedoms and regaining control over our runaway government must start from the bottom up. And that will mean re-learning step by painful step what it actually means to be a government “of the people, by the people and for the people.”
WC: 1692
ABOUT JOHN W. WHITEHEAD
Constitutional attorney and author John W. Whitehead is founder and president of The Rutherford Institute. His most recent books are the best-selling Battlefield America: The War on the American People, the award-winning A Government of Wolves: The Emerging American Police State, and a debut dystopian fiction novel, The Erik Blair Diaries. Whitehead can be contacted at staff@rutherford.org. Nisha Whitehead is the Executive Director of The Rutherford Institute. Information about The Rutherford Institute is available at www.rutherford.org. Publication Guidelines / Reprint Permission
John W. Whitehead’s weekly commentaries are available for publication to newspapers and web publications at no charge. Please contact staff@rutherford.org to obtain reprint permission.
Leading U.S. veterans’ organizations are urging the Biden administration to promptly relax federal marijuana laws, aligning with a growing chorus of voices advocating for rescheduling the substance six months after a recommendation from the U.S. Department of Health and Human Services (HHS). Expressing their sentiments in a recent letter, the groups have called upon the Department of Justice, which oversees the U.S. Drug Enforcement Administration (DEA), to take swift action.
Highlighting the challenges faced by veterans of the United States Armed Forces when they return home, the coalition, comprising entities such as the Minority Veterans of America, AMVETS, Iraq and Afghanistan Veterans of America, the American GI Forum, the Blinded Veterans Association and the American Legion, emphasized the importance of offering a broad spectrum of treatments to address both visible and invisible war wounds.
Currently categorized as a Schedule I drug, alongside drugs such as heroin, marijuana is deemed to have a high potential for misuse and no known medical uses. The HHS has recommended moving it to Schedule III, a significantly less-restrictive classification.
In October 2022, President Joseph Biden initiated a review of the federal cannabis policy, and insiders anticipate a formal decision from the DEA imminently, possibly within the upcoming weeks.
Although the Veterans Affairs (VA) Department isn’t allowed to refuse medical care to veterans who use cannabis in states where it is legal, the agency doesn’t cover prescriptions or offer medical cannabis as a treatment. Last year, a joint recommendation from the Defense Department and the VA advised against cannabis use for PTSD.
However, the veterans’ coalition argues that their members need this option, pointing to an American Legion survey where 82% of participants expressed a preference for federally approved medical marijuana treatment. The coalition underscored that without DEA action, many veterans are reluctant to discuss marijuana use with their VA clinicians, fearing repercussions.
Acknowledging the lengthy administrative scheduling procedure, the groups stressed the advantages of the DEA’s quick reclassification, which could include incorporation into the VHA, the biggest healthcare system in the nation.
Their appeal coincides with mounting Congressional efforts to reform federal marijuana policies. Bipartisan lawmakers from both chambers have proposed numerous bills related to cannabis and veterans, such as enabling VA providers to prescribe medical cannabis in legalized states and mandating marijuana studies on veterans with PTSD and chronic pain.
Public opinion increasingly favors cannabis legalization as well, as evidenced by a Gallup survey indicating that 70% of U.S. adults support it, including a significant number of younger voters and most Republicans.
A cohort of Democrats, led by Chuck Schumer, the Senate Majority Leader, recently pushed the DEA to take marijuana off of scheduling entirely, highlighting this as a once-in-a-decade opportunity for the Biden administration to take action.
Any change to the classification of cannabis at the federal level is likely to result in some improved regulatory environment for cannabis companies and ancillary businesses such as Innovative Industrial Properties Inc. (NYSE: IIPR) as the red tape that goes with this industry can be stifling at times.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
Seeking employment within the cannabis industry? A wide variety of opportunities are available across Canada.
In our March round-up, we’ve curated a sample of current cannabis job openings. From roles in cultivation and regulatory compliance to retail positions, there are diverse avenues for anyone looking to get started or expand their career in the cannabis sector.
SNDL Inc. recently posted a Wholesale Manager, Strategic Partnerships position at the Toronto location. This role will manage bulk biomass procurement and sales and international business opportunities.
Greentone, located in Bécanour, QC is seeking a Directeur(trice) qualité for its quality assurance and control team.
The Certus Group is seeking a new business development-focused Sales Executive, Logistics, Cannabis Division to lead sales efforts in growing their booming Canadian Cannabis segment
BZAM Ltd. has posted several openings, including a full-time Processing Associate in Ancaster, ON.
Motif Labs is also on the hunt for a Production Associate (Cannabis) to support the Extraction or Refining team at its Aylmer, ON location, as well as a Supply Planner responsible for strategic inventory and supply planning.
Circle K continues with several Budtender openings across cities in Ontario, and also one Part-Time Budtender for their Paradise, Newfoundland and Labrador location.
HAVE A JOB POSTING YOU’D LIKE FEATURED ON STRATCANN.COM?
Canadians are cutting back on alcohol purchases, a new report from Statistics Canada suggests, as sales data shows a boost in another substance’s sales.
Recreational cannabis sales by provincial authorities increased by 15.8 per cent year-over-year. Canadians spent a total of $4.7 billion in the 2022 to 2023 fiscal year, according to Statistics Canada, which is a $0.6 billion jump from the previous year.
Research has shown that psychedelics may be useful in the treatment of a range of mental-health conditions, including anxiety, depression and post-traumatic stress disorder. Now, Okanagan researchers are looking into whether psychedelics can help manage alcoholism.
Okanagan Clinical Trials is among other sites in Finland and Canada taking part in this research. The researchers’ objective is to evaluate the effectiveness of psilocybin in treating alcohol use disorder. Psilocybin is the active ingredient found in hallucinogenic mushrooms.
To participate in the trial, all volunteers go through screening after which they participate in 10 therapy sessions, with two of sessions including the administration of 25 mg doses of synthetic psilocybin. Because it’s a randomized study, some patients may receive a placebo during the two sessions.
In a recent interview, trial coordinator Ethan Klukas stated that the 25 mg dose was fairly large. He explained that if an individual received this dose, they entered an altered state for an estimated six to eight hours.
Patients who receive the psychedelic aren’t left to experience the trip alone. They are monitored by therapists who stay in the room with them to help if any symptoms of anxiety come up. During the psychedelic “trip,” the volunteers all listen to a preselected playlist and focus on going inward. After their dosing sessions, individuals can discuss their experience with therapists and explore how it is linked to their goals around alcohol use.
Once the 10-week trial period ends, participants will be observed for an additional three months, during which their consumption of alcohol will be tracked and then compared to consumption prior to therapy.
For the study, which started in August 2022, 160 patients will be needed. The door for recruitment closes in April of this year, but until then, more volunteers are welcome. Generally, volunteers must be healthy and between 19 and 70 years of age. Additionally, they must have received a diagnosis of alcohol use disorder, ranging from moderate to severe cases.
This research is sponsored by Clairvoyant Therapeutic Inc., a biotechnology company based in Vancouver. CEO Damian Kettlewell stated that the company’s objective was to become the first company globally to acquire regulatory approval for the clinical use of psilocybin in treating alcohol use disorder.
With many start-ups such as Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) racing to bring to market various regulator-approved psychedelic treatments, we can expect the range of ailments that these substances can effectively treat to increase over the coming years.
About PsychedelicNewsWire
PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Radicle Femmes is a celebration of women in weed and all are welcome to attend. B2B-focused networking will converge entrepreneurs, marketers, consultants, retail decision-makers, licensed producers, brand reps, and other ancillary services.
The format will see 250+ attendees and includes two panels featuring women in leadership and brand-building gurus, as well as a discussion about the pathway to funding for your business.
Valuable networking, business solutions and lunch included.
Advertisement
Marigold PR has hosted events for women in cannabis since 2017 seeing hundreds of attendees both in-person and virtually. Don’t miss the opportunity to celebrate and promote women in cannabis this March.
Recent Comments